Fifth Third Bancorp Acquires 22,805 Shares of Corteva, Inc. $CTVA

Key Points

• Fifth Third Bancorp raised its stake in Corteva by 14.7%, buying 22,805 shares to hold 178,392 shares valued at about $11.96 million at the end of the quarter.
• Insider Brian Titus sold 8,311 shares on Feb. 20 at an average price of $76.55, generating roughly $636,207 and reducing his holding by 50.7%.
• Analyst coverage is mixed-but-leaning-positive (14 Buys, 9 Holds) with an average target of $86.38; Corteva set FY2026 EPS guidance of $3.45–$3.70 (consensus ~3.62) and pays a $0.18 quarterly dividend (0.9% yield).

Fifth Third Bancorp increased its holdings in Corteva, Inc. (NYSE:CTVA - Free Report) by 14.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 178,392 shares of the company's stock after acquiring an additional 22,805 shares during the period. Fifth Third Bancorp's holdings in Corteva were worth $11,958,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Activest Wealth Management grew its holdings in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company's stock valued at $25,000 after acquiring an additional 200 shares in the last quarter. JPL Wealth Management LLC bought a new stake in shares of Corteva during the 3rd quarter worth $25,000. True Wealth Design LLC boosted its holdings in shares of Corteva by 209.5% in the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company's stock worth $26,000 after buying an additional 264 shares during the last quarter. Redmont Wealth Advisors LLC purchased a new position in shares of Corteva in the 3rd quarter worth about $29,000. Finally, Jackson Grant Investment Advisers Inc. boosted its holdings in shares of Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company's stock worth $30,000 after buying an additional 213 shares during the last quarter. 81.54% of the stock is owned by institutional investors.

Insider Transactions at Corteva

In related news, insider Brian Titus sold 8,311 shares of the business's stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.15% of the company's stock.

Analyst Ratings Changes

CTVA has been the topic of a number of research analyst reports. CICC Research boosted their price target on shares of Corteva from $70.00 to $80.00 and gave the stock an "outperform" rating in a report on Wednesday, February 11th. Weiss Ratings reissued a "hold (c)" rating on shares of Corteva in a report on Wednesday, April 22nd. Wall Street Zen downgraded shares of Corteva from a "buy" rating to a "hold" rating in a report on Saturday, February 7th. UBS Group boosted their price target on shares of Corteva from $80.00 to $88.00 and gave the stock a "neutral" rating in a report on Thursday, April 9th. Finally, Jefferies Financial Group boosted their price target on shares of Corteva from $85.00 to $95.00 and gave the stock a "buy" rating in a report on Monday, March 2nd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $86.38.

Corteva Trading Down 0.1%

Shares of Corteva stock opened at $80.97 on Friday. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63. The stock's 50-day simple moving average is $80.39 and its 200 day simple moving average is $72.12. The stock has a market capitalization of $54.36 billion, a P/E ratio of 51.24, a P/E/G ratio of 2.77 and a beta of 0.59. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43.

Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion for the quarter, compared to analysts' expectations of $4.23 billion. During the same period in the previous year, the business posted $0.32 EPS. The firm's quarterly revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts anticipate that Corteva, Inc. will post 3.62 EPS for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva's payout ratio is currently 45.57%.

Corteva Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.